Yesterday, the Food and Drug Administration (FDA) proposed a ban on over-the-counter (OTC) sales of skin-lightening products containing hydroquinone. Hydroquinone is found in skin bleaching products used primarily for lightening age spots, skin discoloration from years of excess tanning or dark under-eye circles. Research has indicated a possible link to increased cancers.

In the US, there are over 65 companies selling more than 200 skin-bleaching products that contain hydroquinone. Hydroquinone has been banned in Japan, the European Union and Australia. The FDA now wants all OTC and prescription skin-lightening products containing hydroquinone to be classified as new drugs and companies making the skin-bleaching products would need to seek FDA approval to sell them. Likely, the products would stop being available as an OTC product. The proposed ban means that the FDA will take public comments until the end of this year before making any final action.